Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Artificial cells: 35 years.

T M Chang1

  • 1Artificial Cells and Organs Research Centre, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Artificial Organs
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Artificial cells, developed 35 years ago, are versatile biomaterials now revolutionizing medicine and biotechnology. These advanced cells offer innovative treatments for various conditions and drive biotechnological advancements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does conventional early life academic excellence predict later life scientific discovery? An assessment of the lives of great medical innovators.

QJM : monthly journal of the Association of Physicians·2020
Same author

Propentdyopent: the scaffold of a heme metabolite as an electron reservoir in transition metal complexes.

Chemical communications (Cambridge, England)·2016
Same author

Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver.

Oncogene·2013
Same author

Microencapsulation of enzymes, cells, and genetically engineered microorganisms.

Methods in molecular medicine·2011
Same author

Structure and dynamics of N,N-diethyl-N-methylammonium triflate ionic liquid, neat and with water, from molecular dynamics simulations.

The journal of physical chemistry. A·2010
Same author

Neurohormonal control of exocrine pancreas.

Current opinion in gastroenterology·2006
Same journal

Large-Eddy Simulation of the FDA Benchmark Blood Pump: Validation Against Experiments and Implications for Turbulent Flow Mechanisms.

Artificial organs·2026
Same journal

The Warm Revolution: A Meta-Analysis of DCD Versus DBD Liver Transplant Outcomes in the Normothermic Machine Perfusion Era.

Artificial organs·2026
Same journal

Toward Optimal Remote Monitoring in LVAD Recipients: Remaining Challenges Beyond Feasibility.

Artificial organs·2026
Same journal

Advancing Organ Preservation and Perfusion: Introducing the International Society of Organ Preservation and Perfusion Therapy (ISOPPT).

Artificial organs·2026
Same journal

Short Inter-Treatment Interval Treatment With Artificial Liver Support System Reduces 90-Day Transplant-Free Mortality in Patients With Hepatitis B Virus-Related Acute-On-Chronic Liver Failure: A Retrospective Observational Study.

Artificial organs·2026
Same journal

Extracorporeal Albumin Dialysis (OPAL) as Novel Therapeutic Bridging Option in Posthepatectomy Liver Failure.

Artificial organs·2026
See all related articles

Area of Science:

  • Biotechnology
  • Biomedical Engineering
  • Cellular Engineering

Background:

  • Artificial cells were first developed 35 years ago, containing biologically active materials.
  • Their applications have expanded significantly into medicine and biotechnology.
  • Hemoperfusion using artificial cells with adsorbents is a standard treatment for acute poisoning and kidney failure.

Purpose of the Study:

  • To review the diverse applications of artificial cells in medicine and biotechnology.
  • To highlight their current uses and ongoing research for future therapeutic and industrial applications.
  • To underscore the evolution and impact of artificial cell technology.

Main Methods:

  • Review of existing literature and clinical applications of artificial cells.

Related Experiment Videos

  • Description of artificial cell formulations and their incorporation into medical devices.
  • Analysis of ongoing research in areas such as drug delivery, regenerative medicine, and bioproduction.

    • Main Results:

    • Artificial cells are routinely used in hemoperfusion for treating acute poisoning, high blood aluminum/iron, kidney failure, and liver failure.
    • Ongoing research explores artificial cells as red blood cell substitutes and for treating diabetes and liver failure.
    • Enzyme-containing artificial cells are investigated for hereditary enzyme deficiencies and waste conversion (urea, ammonia to amino acids).

    Conclusions:

    • Artificial cells are established therapeutic tools and promising platforms for future medical and biotechnological innovations.
    • Their use in producing monoclonal antibodies and interferons demonstrates their value in biotechnology.
    • Continued research in chemical engineering and medicine promises expanded applications for artificial cell technology.